Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. August 2019 16:05 ET | Quelle: Atreca, Inc.

Atreca Announces Appointment of Dr. Lindsey Rolfe to its Board of Directors

REDWOOD CITY, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the...
13. August 2019 16:05 ET | Quelle: Atreca, Inc.

Atreca Reports Second Quarter 2019 Financial Results and Recent Corporate Developments

REDWOOD CITY, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the...
11. Juli 2019 08:00 ET | Quelle: Atreca, Inc.

Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer and Courtney Phillips as General Counsel

REDWOOD CITY, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human...
19. Juni 2019 21:40 ET | Quelle: Atreca, Inc.

Atreca Announces Pricing of Initial Public Offering

REDWOOD CITY, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Nasdaq: BCEL), a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based...

Vorherige Seite